Abeona therapeutics issues letter to shareholders

New york and cleveland, dec. 22, 2021 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today issued the following letter to shareholders.
ABEO Ratings Summary
ABEO Quant Ranking